Contributing to public health

We develop and manufacture vaccines from our headquarters in the heart of Copenhagen, Denmark to prevent polio, tuberculosis, and other infectious diseases. Vaccination is fundamental for public health, and we are proud to contribute to disease control in more than 50 countries through our collaboration with WHO and UNICEF.

In addition, we manufacture Tuberculin Skin Test for screening and diagnosing of high-risk patients for infection with TB, as well as BCG Culture (Danish Strain 1331) for the standard treatment of intermediate and high-risk non-muscle invasive bladder cancer (NMIBC).

Striving to eradicate polio

We are proud to be part of the Childhood Vaccination Programme and the WHO Global Polio Eradication Initiative. With our dose sparring technology we are providing a significant contribution to expanding inactivated polio vaccine supply.

Our Danish roots

AJ Vaccines was established in 2017 when Statens Serum Institut divested the production of vaccines. Since 1902, Statens Serum Institut has played a crucial role in preventing and treating major epidemics and public diseases in Denmark, providing Danes with a sense of security. Creating safety through vaccination is still at the heart of our work today.

A startup with 100 years of experience

We have been around since the first vaccines and childhood vaccination programmes in Denmark. At the same time, AJ Vaccines is a new company with a new global perspective, projects and development around the world. The combination of tradition and development is what sets us apart. We look to the future and find new ways to provide the whole world the same opportunities for safety and prevention through vaccination that we have in Denmark.